As of 2025-07-15, the EV/EBITDA ratio of Editas Medicine Inc (EDIT) is -0.77. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. EDIT's latest enterprise value is 154.46 mil USD. EDIT's TTM EBITDA according to its financial statements is -201.36 mil USD. Dividing these 2 quantities gives us the above EDIT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.6x - 14.0x | 13.6x |
| Forward P/E multiples | 13.0x - 15.4x | 14.3x |
| Fair Price | (30.27) - (32.77) | (32.55) |
| Upside | -1161.9% - -1249.7% | -1242.1% |
| Date | EV/EBITDA |
| 2025-07-14 | -0.77 |
| 2025-07-11 | -0.78 |
| 2025-07-10 | -0.85 |
| 2025-07-09 | -0.86 |
| 2025-07-08 | -0.77 |
| 2025-07-07 | -0.64 |
| 2025-07-03 | -0.65 |
| 2025-07-02 | -0.65 |
| 2025-07-01 | -0.52 |
| 2025-06-30 | -0.50 |
| 2025-06-27 | -0.53 |
| 2025-06-26 | -0.46 |
| 2025-06-25 | -0.49 |
| 2025-06-24 | -0.52 |
| 2025-06-23 | -0.46 |
| 2025-06-20 | -0.51 |
| 2025-06-18 | -0.56 |
| 2025-06-17 | -0.47 |
| 2025-06-16 | -0.48 |
| 2025-06-13 | -0.40 |
| 2025-06-12 | -0.49 |
| 2025-06-11 | -0.43 |
| 2025-06-10 | -0.46 |
| 2025-06-09 | -0.38 |
| 2025-06-06 | -0.38 |
| 2025-06-05 | -0.33 |
| 2025-06-04 | -0.34 |
| 2025-06-03 | -0.34 |
| 2025-06-02 | -0.32 |
| 2025-05-30 | -0.30 |
| 2025-05-29 | -0.34 |
| 2025-05-28 | -0.36 |
| 2025-05-27 | -0.27 |
| 2025-05-23 | -0.23 |
| 2025-05-22 | -0.26 |
| 2025-05-21 | -0.21 |
| 2025-05-20 | -0.26 |
| 2025-05-19 | -0.20 |
| 2025-05-16 | -0.21 |
| 2025-05-15 | -0.16 |
| 2025-05-14 | -0.16 |
| 2025-05-13 | -0.21 |
| 2025-05-12 | -0.22 |
| 2025-05-09 | -0.19 |
| 2025-05-08 | -0.16 |
| 2025-05-07 | -0.14 |
| 2025-05-06 | -0.14 |
| 2025-05-05 | -0.22 |
| 2025-05-02 | -0.26 |
| 2025-05-01 | -0.26 |